Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLDIC Therapy in Lumbar Degenerative Spinal Stenosis
NCT04492774Phase 4Unknown
- Sponsor
- Sutherland Medical Center
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in lumbar spinal stenosis (LSS) (3 arms), sponsored by Sutherland Medical Center. Primary endpoints: EuroQol 5-Dimension 5-Level at 24 weeks, Oswestry Disability Index at 24 weeks and 1 more. Status: unknown.
02
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on NCT04492774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492774.